Tvardi Therapeutics, Inc. (TVRD)
(Delayed Data from NSDQ)
$7.00 USD
+0.31 (4.63%)
Updated Oct 14, 2025 04:00 PM ET
After-Market: $6.81 -0.19 (-2.71%) 7:50 PM ET
3-Hold of 5 3
F Value A Growth A Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Tvardi Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TVRD 7.00 +0.31(4.63%)
Will TVRD be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for TVRD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TVRD
TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals
TVRD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TVRD
Tivardi downgraded at Raymond James following TTI-101 trial failure
Tvardi Therapeutics (TVRD) Downgraded by Raymond James | TVRD Stock News
Is TVRD poised for gains? Slingshot Bullish shows up after crashing 83.92%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tvardi downgraded to Market Perform from Outperform at Raymond James